Precision Medicine in Relapsed and Refractory Childhood Cancers: Single-center Experience, Literature Review, and Meta-analysis
Objective: To date, the understanding of pediatric tumor genomics and how these genetic aberrations correlate with clinical outcome is lacking. Here, we report our experience with the next-generation sequencing (NGS) test program and discuss implications for the inclusion of molecular profiling into...
Main Authors: | Oz Mordechai, Myriam Weyl Ben-Arush |
---|---|
Format: | Article |
Language: | English |
Published: |
Rambam Health Care Campus
2018-07-01
|
Series: | Rambam Maimonides Medical Journal |
Subjects: | |
Online Access: | https://www.rmmj.org.il/issues/38/863/manuscript |
Similar Items
-
Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
by: Michal Kýr, et al.
Published: (2020-03-01) -
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside
by: Kristyna Polaskova, et al.
Published: (2020-02-01) -
Precision Medicine for the Management of Therapy Refractory Colorectal Cancer
by: Hossein Taghizadeh, et al.
Published: (2020-12-01) -
Precision medicine in relapsed or refractory pediatric solid tumors: a collaborative Spanish initiative
by: Pablo Gargallo, et al.
Published: (2019-07-01) -
Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
Published: (2020)